Abogen Biosciences
PrivateLast Round
Grant
Feb 4, 2026
Est. Valuation
$3.1B
Total Funding Raised
$1.13B
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Abogen Biosciences is a biotechnology company that develops mRNA-based therapeutics and vaccines for infectious diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abogen Biosciences Comparables
Compare Abogen Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou CureMed Biopharma Technology Co., Ltd | 86% | |
| Stemirna Therapeutics | 85% | |
| Innorna | 83% | |
Abogen Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 4, 2026 | ||||
| Series C Extension | Nov 29, 2021 | ||||
| Series C | Aug 19, 2021 | ||||
| Series B | Apr 7, 2021 | ||||
| Series A | Oct 27, 2020 |
Key People
Founding team and executive leadership
Abogen Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series C, Series B |
| Oriental Spring Capital | Series C |
| Alwin Capital | Series C |
| Jifeng Ventures | Series B |
| BioTrack Capital | Series C, Series B |
| Youshan Capital | Series C |
| Loyal Valley Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 3841% MoM, reaching 2.7K.
- Apr 21, 2026
Phase I results for mRNA T-cell engager ABO2203 presented at AACR Annual Meeting.
Abogen Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abogen Biosciences's valuation, stock price, and market status.